Abstract:The title compound n-propyl-4-[2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino] benzoate (C23H25N3O5) was synthesized by the reaction of 2-methanesulfonyl-4,6-dimethoxy pyrimidine and N-(4'-propoxycarbonylphenyl)-2-hydroxybenzylamine in THF, and its structure was determined by single-crystal X-ray diffraction. The crystal is of monoclinic, space group P2/n with a = 14.8504(8), b = 9.4420(4), c = 16.3129(9) Angstrom, beta = 104.881(1)degrees, V = 2210.6(2) Angstrom(3), Z = 4, D-c = 1.272 g/cm(3), F(000) = 896.00, mu(MoKalpha) = 0.91cm(-1), R = 0.051 and wR = 0.118. Of the 19761 collected reflections, 5004 were unique. The title compound was also characterized by elemental analysis, IR, MS and H NMR. In the molecule there exist three different planes. In each of them a conjugated system is formed. The dihedrals between the pyrimidine plane and two phenyl planes (C(7)similar toC(12), C(14)similar toC(19)) are 99.18 and 164.15degrees, respectively, and the dihedral between these two phenyl rings is 94.93degrees. The conformation of the title compound is of boat-like.

(3S,4r)-3-ethyl-4-hydroxy-3-(3-methoxyphenyl)-1-methylazepanium (2R,3r)-2,3-bis(benzoyloxy)-3-carboxypropionate

N-(2,4-Dinitrophenyl)dehydroabietylamine

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

2,2′-Diamino-4,4′-bi-1,3-thiazol-3,3′-diium Bis(2,2′-Diamino-4,4′-bi-1,3-thiazol-3-ium) Tetrakis(2-Nitrobenzoate)

2-Amino-4-methylpyridinium 4-Aminobenzoate

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

2-(2-Chloro-phen-yl)-N-cyclo-hexyl-2-oxoacetamide.

N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

(E)-4,4′-diazastilbene–4,4′-oxydibenzoic Acid (1/1)

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Ethyl 2-amino-4-(4-methylphenyl)-4H-benzo[f]chromene-3-carboxylate

Synthesis and Crystal Structure of (S)-N-(hexahydro-2-oxo-1h-azepin-3-yl)-3-phenyl-2-propenamide

Ethyl 4-(4-Chloro-phen-yl)-2-methyl-5-oxo-5,6,7,8-tetra-hydro-quinoline-3-carboxyl-ate.

Crystal Structure Of Ethyl 4-Benzoyl-1a,2,3,4-Tetrahydro-3-Methyl-1a-(4-Methylphenyl)-1h-Azirino[1, 2-A][1,5]Benzodiazepine-1-Carboxylate (C28h28n2o3)

Synthesis and Crystal Structure of N-Propyl-4-[2-(4,6- Dimethoxypyrimidin-2-yloxy)benzylamino] Benzoate

(3r,4s)-1-(4-Methoxyphenyl)-2-Oxo-4-(3-Vinylphenyl) Azetidin-3-Yl Acetate